Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FK.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GE.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GE.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HE.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.4.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.4.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.4.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.99EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.99EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.99ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.99ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.99EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.99EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.99ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.99ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used